BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3813654)

  • 21. [Ocular manifestation of progressive essential telangiectases].
    Gantenbein C; Seiter S; Weik R; Reinhold U; Ruprecht KW; Tilgen W
    J Fr Ophtalmol; 2001 Jan; 24(1):45-8. PubMed ID: 11240470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy.
    Bollinger A; Jäger K; Siegenthaler W
    Arch Intern Med; 1986 Aug; 146(8):1541-5. PubMed ID: 3729634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistological evaluation of endothelial markers and basement membrane components in port-wine stains.
    Mitsuhashi Y; Odermatt BF; Schneider BV; Schnyder UW
    Dermatologica; 1988; 176(5):243-50. PubMed ID: 3289978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal telangietasia as a cause of severe blood loss in systemic sclerosis.
    Rosekrans PC; de Rooy DJ; Bosman FT; Eulderink F; Cats A
    Endoscopy; 1980 Sep; 12(5):200-4. PubMed ID: 6968678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enterocyte-labelling index in the duodenal mucosa of patients with progressive systemic sclerosis (PSS).
    Hendel L; Ammitzbøll T; Petri M
    Acta Pathol Microbiol Immunol Scand A; 1986 Mar; 94(2):107-11. PubMed ID: 3716798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential dermal microvascular and perivascular changes in the development of scleroderma.
    Prescott RJ; Freemont AJ; Jones CJ; Hoyland J; Fielding P
    J Pathol; 1992 Mar; 166(3):255-63. PubMed ID: 1517881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vascular basement membrane in systemic sclerosis skin: heterogeneity of type IV collagen.
    Hoyland JA; Newson L; Jayson MI; Freemont AJ
    Br J Dermatol; 1993 Oct; 129(4):384-8. PubMed ID: 8217749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural changes of musculo-cutaneous arterioles in human atherosclerosis.
    Baltă N; Mandache E
    Rev Roum Med Intern; 1974; 11(2):241-5. PubMed ID: 4824734
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of the oral manifestations of systemic sclerosis.
    Nagy G; Kovács J; Zeher M; Czirják L
    Oral Surg Oral Med Oral Pathol; 1994 Feb; 77(2):141-6. PubMed ID: 8139831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructure of muscle microvasculature in progressive systemic sclerosis: relation to clinical weakness.
    Russell ML; Hanna WM
    J Rheumatol; 1983 Oct; 10(5):741-7. PubMed ID: 6644696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vascular manifestations in systemic sclerosis (scleroderma)].
    Cafagna D; Melon F; Balbi M; Ponte E
    Minerva Med; 1998 May; 89(5):153-61. PubMed ID: 9676180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of telangiectasia in scleroderma.
    Mould TL; Roberts-Thomson PJ
    Asian Pac J Allergy Immunol; 2000 Dec; 18(4):195-200. PubMed ID: 11316039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of body image dissatisfaction and the psychological impact of systemic sclerosis-related telangiectases.
    Ennis H; Herrick AL; Cassidy C; Griffiths CE; Richards HL
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):12-7. PubMed ID: 23324653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo study of scleroderma by non-invasive techniques.
    Kalis B; De Rigal J; Léonard F; le Lévêque JL; De Riche O; Corre YL; Lacharriere OD
    Br J Dermatol; 1990 Jun; 122(6):785-91. PubMed ID: 2369559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructure of the microvasculature in skin affected by systemic scleroderma.
    Saito Y; Ishikawa H
    J Dermatol; 1976 Aug; 3(4):127-33. PubMed ID: 15633966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telangiectases in Systemic Sclerosis.
    Jacobson R; Agnihothri R; Haemel A
    JAMA Dermatol; 2021 Apr; 157(4):457. PubMed ID: 33595597
    [No Abstract]   [Full Text] [Related]  

  • 37. Microcirculatory functions in systemic sclerosis: additional parameters for therapeutic concepts?
    Albrecht HP; Hiller D; Hornstein OP; Bühler-Singer S; Mück M; Gruschwitz M
    J Invest Dermatol; 1993 Aug; 101(2):211-5. PubMed ID: 8345223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between nailfold capillary microscopy and salivary capillary basement membrane width in Raynaud's disease and progressive systemic sclerosis.
    DeBure C; Fiessinger JN; Priollet P; Camilleri JP; Vayssairat M; Kazandjian S; Housset E
    J Rheumatol; 1985 Apr; 12(2):279-82. PubMed ID: 4032402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis.
    Gay RE; Buckingham RB; Prince RK; Gay S; Rodnan GP; Miller EJ
    Arthritis Rheum; 1980 Feb; 23(2):190-6. PubMed ID: 6987989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous fibrinolytic activity in scleroderma.
    Lotti T; Cerinic MM; Marmugi D; Fabbri P
    Clin Exp Rheumatol; 1985; 3(3):249-53. PubMed ID: 4053443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.